Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates

We evaluated the pharmacokinetics of stavudine (d4T) and didanosine (ddI) in neonates. Eight neonates born to human immunodeficiency virus-infected mothers were enrolled to receive 1 mg of d4T per kg of body weight twice daily and 100 mg of ddI per m(2) once daily in combination with nelfinavir for...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Rongkavilit, Chokechai, Thaithumyanon, Pimolrat, Chuenyam, Theshinee, Damle, Bharat D., Limpongsanurak, Sompop, Boonrod, Chantana, Srigritsanapol, Aeumporn, Hassink, Elly A. M., Hoetelmans, Richard M. W., Cooper, David A., Lange, Joep M. A., Ruxrungtham, Kiat, Phanuphak, Praphan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90873/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709344/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3585-3590.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!